Citius Oncology (CTOR) Shares Outstanding (Entity) (2021 - 2026)
Powered by 
Analysis
Citius Oncology (CTOR) Shares Outstanding (Entity) (2021 - 2026) Analysis & Trends
Peer Set
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | Shares Outstanding (Entity.) (Qtr) |
|---|---|---|---|---|---|
| 1 | Amgen | 211.73 Bn | 197.74 Bn | 7.24 Bn | 540.60 Mn |
| 2 | Gilead Sciences | 180.92 Bn | 177.74 Bn | 6.22 Bn | 1.24 Bn |
| 3 | Vertex Pharmaceuticals | 132.16 Bn | 124.30 Bn | 2.84 Bn | 253.35 Mn |
| 4 | Regeneron Pharmaceuticals | 82.89 Bn | 74.90 Bn | 3.93 Bn | 102.80 Mn |
| 5 | Argenx Se | 61.41 Bn | 56.23 Bn | 1.37 Bn | - |
| 6 | Moderna | 53.99 Bn | 48.85 Bn | 52.00 Mn | 399.00 Mn |
| 7 | Alnylam Pharmaceuticals | 34.48 Bn | 31.18 Bn | 992.69 Mn | 133.73 Mn |
| 8 | Biogen | 31.15 Bn | 29.86 Bn | 1.96 Bn | 147.75 Mn |
| 9 | Roivant Sciences | 30.05 Bn | 30.05 Bn | 1.16 Mn | 722.67 Mn |
| 10 | Citius Oncology | 101.41 Mn | 101.41 Mn | 1.00 Mn | 105.76 Mn |
Historic Data
Download Data
Historic Data
| Date | Value |
|---|---|
| Jun 30, 2026 | 105.76 Mn |
| Mar 31, 2026 | 92.98 Mn |
| Dec 31, 2025 | 84.80 Mn |
| Sep 30, 2025 | 83.51 Mn |
| Jun 30, 2025 | 71.55 Mn |
| Mar 31, 2025 | 71.55 Mn |
| Dec 31, 2024 | 71.55 Mn |
| Sep 30, 2024 | 71.55 Mn |
| Jun 30, 2024 | 6.65 Mn |
| Mar 31, 2024 | 4.74 Mn |
| Dec 31, 2023 | 67.50 Mn |
| Sep 30, 2023 | 8.94 Mn |
| Jun 30, 2023 | 9.02 Mn |
| Mar 31, 2023 | 9.02 Mn |
| Dec 31, 2022 | 3.21 Mn |
| Sep 30, 2022 | 1.73 Mn |
| Dec 31, 2021 | 1.73 Mn |